[ATP-sensitive potassium channels and changes in their functional activity during streptozocin-induced diabetes mellitus].
D000255:Adenosine Triphosphate / Q000378:metabolism*; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D015221:Potassium Channels / Q000187:drug effects*; D051381:Rats; D017208:Rats, Wistar; D014661:Vasoconstriction / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D015221:Potassium Channels; D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D000255:Adenosine Triphosphate; D011188:Potassium; D009638:Norepinephrine
ATF-chutlyvi kaliievi kanaly ta zmin ïkh funktsional'noï aktyvnosti pry tsukrovomu diabeti, vyklykanomu vvedenniam streptozototsynu.